Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Panzig, B.
Right arrow Articles by Gründling, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panzig, B.
Right arrow Articles by Gründling, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 43, 415-418
© 1999 The British Society for Antimicrobial Chemotherapy

Brief reports

A large outbreak of multiresistant Pseudomonas aeruginosa strains in north-eastern Germany

Brigitte Panziga,*, Gudrun Schröde ra, F.-A. Pittenb and M. Gründlingc

a Institute of Medical Microbiology b Institute of Hygiene and Environmental Medicine c Department for Anaesthesiology and Intensive Medicine, University of Greifswald, Germany

Multiply-resistant Pseudomonas aeruginosa were first detected in north-eastern Germany at the end of 1996; since then they have been isolated predominantly from patients in intensive care units. Colonization/infection, especially of the respiratory tract, has been demonstrated in 80 patients, with strains resistant to ß-lactams, carbapenems, aminoglycosides and quinolones. Amikacin showed in-vitro synergy with cefepime, ceftazidime or piperacillin/tazobactam. Horizontal transfer of strains was followed by PFGE and identical strains were detected in the environment, but the source of infection was not established. Rigorous infection control and restricted clinical use of carbapenems limited further dissemination of this outbreak.

* Corresponding author. Tel: +49-3834-865556; Fax: +49-3834-865561


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
D. Hocquet, X. Bertrand, T. Kohler, D. Talon, and P. Plesiat
Genetic and Phenotypic Variations of a Resistant Pseudomonas aeruginosa Epidemic Clone
Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1887 - 1894.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
F. Luzzaro, E. Mantengoli, M. Perilli, G. Lombardi, V. Orlandi, A. Orsatti, G. Amicosante, G. M. Rossolini, and A. Toniolo
Dynamics of a Nosocomial Outbreak of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum {beta}-Lactamase
J. Clin. Microbiol., May 1, 2001; 39(5): 1865 - 1870.
[Abstract] [Full Text]

Home page
 Mol. Pathol.Home page
P C Y Woo, P K L Leung, K W Leung, and K Y Yuen
Identification by 16S ribosomal RNA gene sequencing of an Enterobacteriaceae species from a bone marrow transplant recipient
Mol. Pathol., August 1, 2000; 53(4): 211 - 215.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.